News & Events

January 02, 2019 – Banner Receives FDA Tentative Approval for BAFIERTAM for the Treatment of Relapsing Forms of Multiple Sclerosis

View full release as a pdf here:

BAFIERTAM FDA Tentative Approval 01 02 2019.pdf (69.9 KB)